Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lung tissue repair is a complex biological process involving multiple cell types, signaling pathways, and molecular mediators that restore lung structure and function after injury. It is essential for maintaining respiratory health and preventing chronic lung diseases. Key cell types include AT2 cells, basal cells, club cells, BASCs, and macrophages. Major molecular mediators include growth factors (TGF-α, KGF/FGF7, HGF), interleukins, chemokines, prostaglandins, and matrix metalloproteinases. Key signaling pathways are Sonic Hedgehog, Rho GTPases, MAP Kinase Pathways, STAT3, and Wnt Signaling. Effective lung tissue repair is vital for recovery from pneumonia/infection-induced damage but may be impaired by repeated/chronic insults leading to fibrosis or persistent loss-of-function diseases.
Enhancing endogenous regeneration while minimizing maladaptive remodeling/fibrosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lung Tissue Repair.